Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know
- PMID: 22289914
- PMCID: PMC3424745
- DOI: 10.1113/jphysiol.2011.220855
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know
Abstract
Endogenous cannabinoids (endocannabinoids, eCBs) are ubiquitous regulators of synaptic transmission in the brain, mediating numerous forms of short- and long-term plasticity, and having strong influences on synapse formation and neurogenesis. Their roles as retrograde messengers that suppress both excitatory and inhibitory transmission are well-established. Yet, despite intensive investigation, many basic aspects of the eCB system are not understood. This brief review highlights recent advances, problems that remain unresolved, and avenues for future exploration. While 2-arachidonoylglycerol (2-AG) is probably the major eCB for intercellular CB1R-dependent signalling, anandamide (AEA) has come to the forefront in several novel contexts, both as a dual endovanilloid/endocannabinoid that regulates synaptic transmission acutely and as the source of a steady eCB tone in hippocampus. Complexities in the cellular processing of 2-AG are receiving renewed attention, as they are increasingly recognized as major determinants of how 2-AG affects cells. Long-standing fundamental issues such as the synthesis pathway for AEA and the molecular mechanism(s) underlying cellular uptake and release of eCBs remain problematical.
Figures

Similar articles
-
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step.Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20564-9. doi: 10.1073/pnas.0706873104. Epub 2007 Dec 11. Proc Natl Acad Sci U S A. 2007. PMID: 18077376 Free PMC article.
-
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.Nat Neurosci. 2008 Feb;11(2):152-9. doi: 10.1038/nn2042. Epub 2008 Jan 20. Nat Neurosci. 2008. PMID: 18204441
-
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.J Physiol. 2011 Oct 15;589(Pt 20):4857-84. doi: 10.1113/jphysiol.2011.212225. Epub 2011 Aug 1. J Physiol. 2011. PMID: 21807615 Free PMC article.
-
The endocannabinoid system in neurodegeneration.Ital J Biochem. 2006 Sep-Dec;55(3-4):283-9. Ital J Biochem. 2006. PMID: 17274532 Review.
-
Retrograde signaling by endocannabinoids.Curr Opin Neurobiol. 2002 Jun;12(3):324-30. doi: 10.1016/s0959-4388(02)00328-8. Curr Opin Neurobiol. 2002. PMID: 12049940 Review.
Cited by
-
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling.Neuron. 2013 May 8;78(3):498-509. doi: 10.1016/j.neuron.2013.02.036. Epub 2013 Apr 11. Neuron. 2013. PMID: 23583622 Free PMC article.
-
Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.J Neurosci. 2013 Nov 13;33(46):18331-42. doi: 10.1523/JNEUROSCI.2971-12.2013. J Neurosci. 2013. PMID: 24227742 Free PMC article.
-
Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment.Front Endocrinol (Lausanne). 2019 May 17;10:311. doi: 10.3389/fendo.2019.00311. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31156558 Free PMC article.
-
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons.Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3276-85. doi: 10.1098/rstb.2011.0383. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108546 Free PMC article. Review.
-
Brain activity of anandamide: a rewarding bliss?Acta Pharmacol Sin. 2019 Mar;40(3):309-323. doi: 10.1038/s41401-018-0075-x. Epub 2018 Jul 26. Acta Pharmacol Sin. 2019. PMID: 30050084 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources